| Literature DB >> 29184054 |
Mingzhe Zhao1, Jiarun Yang1, Wenbo Wang1, Jingsong Ma1, Jian Zhang1, Xueyan Zhao1, Xiaohui Qiu1, Xiuxian Yang1, Zhengxue Qiao1, Xuejia Song1, Lin Wang1, Shixiang Jiang1, Erying Zhao1, Yanjie Yang2.
Abstract
Exposure to stress predicts the occurrence of posttraumatic stress disorder (PTSD) in individuals harboring the serotonin transporter promoter variant 5-HTTLPR. We carried out a meta-analysis of studies investigating the interaction between 5-HTTLPR, stress, and PTSD to clarify the interrelatedness of these factors. We reviewed all relevant studies published in English before May 2016. The Lipták-Stouffer z-score method for meta-analysis was applied to combined data. The z score was separately calculated for the stressful life events, childhood adversity, bi- and triallelic loci, and cross-sectional and longitudinal studies subgroups. A total of 14 studies with 15,883 subjects met our inclusion criteria. We found strong evidence that the presence of 5-HTTLPR influenced the relationship between stress and PTSD (P = 0.00003), with the strongest effects observed in the cross-sectional and longitudinal groups (P = 0.01 and 2.0 × 10-6, respectively). Stressful life events and childhood adversity separately interacted with 5-HTTLPR in PTSD (P = 2.0 × 10-8 and 0.003, respectively). When the studies were stratified by locus classification, the evidence was stronger for the triallelic (P = 4.0 × 10-8) than for the biallelic (P = 0.054) locus subgroup. There was strong evidence that 5-HTTLPR influences the relationship between stress and PTSD.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29184054 PMCID: PMC5705670 DOI: 10.1038/s41598-017-15168-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow chart of study screening process.
Studies on the interaction between 5-HTTLPR polymorphism, life stress, and PTSD included in the meta-analysis.
| Study | No. of participants | Males, N (%) | Age, range or mean (years) | Ancestry | Study design | Stressor | Stressor measure | Diagnostic instrument | PTSD measure | Allele sensitivity | Averaged 1-tailed P value | Lipták-Stouffer P value after study exclusion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kilpatrick | 589 | 374 (63.5) | ≥ 60 (76.6%) | Mixed | Cross-sectional | SLEs | MOSM | DSM-IV | Last 6–9 months | S/Lg | 0.047 | 5.0 × 10−5 |
| Grabe | 3045 | 1571 (51.6) | 20–79 | European | Longitudinal | CA& SLEs | SCID | SCID | lifetime | La | 0.005 | 6.5 × 10−4 |
| Xie | 1252 | 651 (52) | 17–79 | Mixed | Cross-sectional | CA& SLEs | SSADDA | SSADDA | lifetime | S/Lg | 0.019 | 1.1 × 10−4 |
| Kolassa | 408 | 218 (53.4) | 17–68 | African | Cross-sectional | SLEs | PDS | DSM-IV | lifetime | S | 0.055 | 4.0 × 10−5 |
| Holman | 711 | Not reported | No report | European | Longitudinal | SLEs | DIS trauma section | PCL | Last 1 year | S/Lg | 0.005 | 8.0 × 10−5 |
| Mercer | 1045 | 0 | 18–45 | Mixed | Longitudinal | SLEs | TLEQ/DEQ | TLEQ/DEQ | Last 30 days | S/Lg | 0.003 | 1.3 × 10−4 |
| Xie | 6430 | 3551 (55) | 17–85 | Mixed | Case-control | CA | Self-edited questionnaire | SSADDA | lifetime | S | 0.122 | 0.00000 |
| Wald | 1085 | 1085 (100) | 18–24 | Mixed | Longitudinal | SLEs | Self-edited questionnaire | PCL | Current | S/Lg | 0.003 | 1.4 × 10−4 |
| Pietrzak | 149 | 63 (41.1) | 18–92 | Mixed | Cross-sectional | SLEs | Self-edited questionnaire | PCL | Last 2–5 months | S | 0.096 | 3.0 × 10−5 |
| La Greca | 116 | 53 (46) | 8.85 | Mixed | Cross-sectional | SLEs | HURTE-R | PTSD-RI-R | After 8 months | S | 0.500 | 3.0 × 10−5 |
| Walsh | 682 | 254 (37) | 43.63 | African | Cross-sectional | CA | CTQ | PCL-S | lifetime | S | 0.009 | 7.0 × 10−5 |
| Telch | 133 | 114 (85.7) | 23.5 | Mixed | Longitudinal | SLEs | CEL | PCL-S | Current | S/Lg | 0.012 | 4.0 × 10−5 |
| Tian | 183 | 99 (54.1) | 15.2 | Asian | Cross-sectional | SLEs | Self-edited questionnaire | PCL-C | Last 3 years | S | 0.008 | 4.0 × 10−5 |
| Drevo | 55 | 0 | 18–70 | Mixed | Cross-sectional | SLEs | Self-edited questionnaire | PSS-SR-17 | Current | S | 0.500 | 3.0 × 10−5 |
|
|
|
| ||||||||||
|
|
|
CA, childhood adversity; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, fourth revision; SLEs, stressful life events; SCID, the Structured Clinical Interview for DSM-IV; SSADDA, Semi-Structured Assessment for Drug Dependence and Alcoholism interview; PCL, the PTSD Checklist-Civilian Version; TLEQ, Traumatic Life Events Questionnaire; DEQ, the Distressing Event Questionnaire; PTSD-RI-R, the Posttraumatic Stress Disorder-Reaction Index for Children-Revised; PCL-S, the PTSD Checklist-Specific version; PCL-C, the PTSD Checklist-Civilian Version; PSS-SR-17, Posttraumatic Stress Disorder Symptom Scale-Self Report-17; MOSM, Medical Outcome Study Module; PDS, Posttraumatic Diagnostic Scale; DIS, Diagnostic Interview Schedule; HURTE-R, The Hurricane Related Traumatic Experiences-Revised; CTQ, The Childhood Trauma Questionnaire; CEL, Combat Experiences Log.
Figure 2Forest plot of 14 human observational studies for the interaction of 5-HTTLPR genotype and life stress on PTSD. The squares mark indicate the one-tailed P value for each study, where lower values denote greater stress sensitivity of S allele carriers and higher values correspond to greater stress sensitivity of L allele carriers. The size of the box reflects relative sample size. The red triangle indicates the overall result of meta-analysis. Black squares mark studies that indexed stressful life events; Dark blue indicates childhood adversity; and light blue indicates studies that included both stressful life events and childhood adversities; The squares with red border indicate S/Lg alleles; The squares with blue border indicate S alleles; and the squares with purple border indicate La alleles. The squares with w-resize indicate longitudinal studies and the squares with e-resize indicate cross-sectional studies.
Studies included in the life stress group meta-analysis.
| Source, year | No. of subjects | 1-Tailed P value | P value after study exclusion |
|---|---|---|---|
| Kilpatrick | 589 | 0.047 | 6.02 × 10−8 |
| Grabe | 3045 | 0.005 | 3.70 × 10−9 |
| Xie | 1252 | 0.019 | 1.80 × 10−7 |
| Kolassa | 408 | 0.055 | 4.44 × 10−8 |
| Holman | 711 | 0.005 | 1.74 × 10−7 |
| Mercer | 1045 | 0.003 | 4.31 × 10−7 |
| Wald | 1085 | 0.003 | 4.64 × 10−7 |
| Pietrzak | 149 | 0.096 | 2.63 × 10−8 |
| La Greca | 116 | 0.500 | 1.98 × 10−8 |
| Telch | 133 | 0.012 | 3.09 × 10−8 |
| Tian | 183 | 0.008 | 3.74 × 10−7 |
| Drevo | 55 | 0.500 | 2.01 × 10−8 |
|
|
| ||
|
|
|
|
Studies included in the childhood adversity group meta-analysis.
| Source, year | No. of Participants | 1-Tailed P value | P Value after study exclusion |
|---|---|---|---|
| Grabe | 3045 | 0.005 | 0.0378 |
| Xie | 1252 | 0.019 | 0.0088 |
| Xie | 6430 | 0.122 | 0.0001 |
| Walsh | 682 | 0.009 | 0.0065 |
|
|
| ||
|
|
|
|
Studies included in the cross-sectional group meta-analysis.
| Source, year | No. of participants | 1-Tailed P value | P Value after study exclusion |
|---|---|---|---|
| Kilpatrick | 589 | 0.047 | 0.024 |
| Xie | 1252 | 0.019 | 0.040 |
| Kolassa | 408 | 0.055 | 0.022 |
| Xie | 6430 | 0.122 | 3.0 × 10−5 |
| Pietrzak | 149 | 0.096 | 0.018 |
| La Greca | 116 | 0.500 | 0.017 |
| Walsh | 682 | 0.009 | 0.030 |
| Tian | 183 | 0.008 | 0.020 |
| Drevo | 55 | 0.500 | 0.017 |
|
|
| ||
|
|
|
|
Studies included in the longitudinal group meta-analysis.
| Source, year | No. of participants | 1-Tailed P value | P value after study exclusion |
|---|---|---|---|
| Grabe | 3045 | 0.005 | 9.0 × 10−7 |
| Holman | 711 | 0.005 | 2.0 × 10−5 |
| Mercer | 1045 | 0.003 | 9.0 × 10−5 |
| Wald | 1085 | 0.003 | 4.0 × 10−5 |
| Telch | 133 | 0.012 | 3.0 × 10−6 |
|
|
| ||
|
|
|
|
Studies included in the S/Lg allele group meta-analysis.
| Source, year | No. of participants | 1-tailed P value | P value after study exclusion |
|---|---|---|---|
| Kilpatrick | 589 | 0.047 | 2.0 × 10−7 |
| Xie | 1252 | 0.019 | 2.0 × 10−7 |
| Holman | 711 | 0.005 | 1.0 × 10−6 |
| Mercer | 1045 | 0.003 | 2.0 × 10−6 |
| Wald | 1085 | 0.003 | 2.0 × 10−6 |
| Telch | 133 | 0.012 | 9.0 × 10−8 |
|
|
| ||
|
|
|
|
Studies included in the S allele group meta-analysis.
| Source, year | No. of participants | 1-tailed P value | P value after study exclusion |
|---|---|---|---|
| Kolassa | 408 | 0.055 | 0.06 |
| Xie | 6430 | 0.122 | 2.0 × 10−4 |
| Pietrzak | 149 | 0.096 | 0.05 |
| La Greca | 116 | 0.500 | 0.05 |
| Walsh | 682 | 0.009 | 0.08 |
| Tian | 183 | 0.008 | 0.06 |
| Drevo | 55 | 0.500 | 0.05 |
|
|
| ||
|
|
|
|